Request Appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Romesser
Dr. Romesser is the Director of Colorectal and Anal Cancer Radiation Oncology and an Assistant Member of Memorial Sloan Kettering Cancer Center in the Department of Radiation Oncology and the Early Drug Development Service in the Department of Medicine. Dr. Romesser is a member of the NRG Oncology colorectal and non-colorectal committees is involved in industry and NCI sponsored corporative group clinical trials in rectal and anal cancer. Notably, he was inducted into the Alpha Omega Alpha Honor Medical Society in 2011.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2012 - 2016- Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2011 - 2012
Boston University School of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 2021 - 2025
NY State Medical License 2012 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer Start of enrollment: 2021 Mar 18
Roles: Contact
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2022 Dec 09
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Nonoperative Management of Mismatch Repair-Deficient Tumors.Andrea Cercek, Michael B Foote, Benoit Rousseau, J Joshua Smith, Jinru Shia
The New England Journal of Medicine. 2025-04-27 - Clocking Recurrence: Circulating Tumor HPV DNA Kinetics in Anal Cancer.Aron Bercz, Daniel L Faden, J Joshua Smith, Paul B Romesser
Clinical Cancer Research. 2025-04-15 - 1 citationsNonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy.Marsha Reyngold, Joshua D Schoenfeld, Eileen M O'Reilly, Anna M Varghese, Charlie White
JAMA Oncology. 2025-04-10
Authored Content
- PSA Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma PatientsOctober 2017
Press Mentions
Understanding the ERASur Clinical TrialSeptember 18th, 2024- Long Radiotherapy Course Shows Better Organ Preservation in Rectal CancerSeptember 10th, 2024
Grant Support
- Investigating the contribution of cellular senescence to the efficacy of radiation therapy.SLOAN-KETTERING INST CAN RESEARCH2021–2026
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
